Clinical Trials Logo

Laryngectomy; Status clinical trials

View clinical trials related to Laryngectomy; Status.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06137378 Not yet recruiting - Clinical trials for Squamous Cell Carcinoma of Head and Neck

European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]

ELOS
Start date: November 2024
Phase: Phase 2
Study type: Interventional

ELOS is a prospective, randomized, open-label, controlled, two-armed parallel group, phase II multicentre trial in local advanced stage III, IVA/B head and neck squamous cell carcinoma of the larynx or hypopharynx (LHNSCC) with PD-L1-expression within tumor tissue biopsy, calculated as CPS ≥ 1 curable by total laryngectomy. Induction chemotherapy (IC) with Docetaxel and Cisplatin (TP) followed by radiation will be compared to additional PD-1 inhibition. Patients will be selected after short induction early response evaluation after the first cycle IC (IC-1) aiming on larynx organ-preservation by additional 2 cycles IC followed by radiotherapy (69.6 Gy) for responders achieving endoscopic estimated tumor surface shrinkage (ETSS) ≥ 30%. Nonresponders (ETSS < 30% or progressing disease) will receive total laryngectomy and selective neck dissection followed by postoperative radiation or chemoradiation according to the recommendation of the clinics multidisciplinary tumor board. However, Patients randomized into the intervention arm starting day 1 will receive 200 mg Pembrolizumab (MK-3475) i.v. in 3-week cycle (q3w) for 17 cycles (12 months). Treatment with pembrolizumab will continue in the experimental arm regardless of ETSS status after IC-1 in both responders and laryngectomized nonresponders, independent from subsequent decision on adjuvant therapy after TL.

NCT ID: NCT06084611 Not yet recruiting - Clinical trials for Laryngectomy; Status

Long Term Effects of Heat and Moisture Exchangers (HMEs)

Start date: December 2023
Phase: N/A
Study type: Interventional

Assessment of long term effect of Provox Life HME use on pulmonary symptoms in laryngectomized patients.